Literature DB >> 30671724

Correlations between Histological and Array Comparative Genomic Hybridization Characterizations of Wilms Tumor.

Ming-Ru Chiang1, Chi-Wen Kuo2,3,4,5, Wen-Chung Wang6, Tai-Cheng Hou7, Chen-Yun Kuo7, Meng-Yao Lu8, Yen-Chein Lai9.   

Abstract

Wilms tumor, or nephroblastoma, is the most common pediatric renal malignancy. Its diagnosis is principally based on histology. Several genetic loci have been shown to be associated with Wilms tumor formation, including WT1, WT2, FWT1, FWT2, CTNNB1, WTX, and TP53. Other loci, such as 1p, 2q, 7p, 9q, 12q, 14q, 16q, 17p, and 22, have also been implicated in the etiology of Wilms tumor. The aim of this study is to elucidate the molecular pathogenesis of this tumor. In the present study, we analyzed the histological appearance and copy number aberrations using array comparative genomic hybridization of six Wilms tumors without somatic mutation in the WT1 gene. Many chromosomal aberrations on array comparative genomic hybridization analysis revealed that the genetics of Wilms tumors are extremely complex. Amplifications and deletions of large DNA fragments were observed in some samples. Amplifications of NDUFV1, ZIC2, SIX1, NR2F2, MIR1469, SOX9, JAG1, MIR6870, and GNAS were found in all six Wilms tumors. Moreover, amplifications of five genes were identified in the Wilms tumors of stromal type and amplifications of at least 10 genes were identified in the Wilms tumors of epithelial type. Our results indicated that amplifications of nine genes are the essential events in the tumorigenesis of Wilms tumor, which may inform its clinical and therapeutic management. In addition, mixed type Wilms tumor may be the heterogeneous group able to be classified using genetic results of epithelial and stromal components based on immunohistochemistry.

Entities:  

Keywords:  Array comparative genomic hybridization; Molecular pathogenesis; Nephroblastoma; Wilms tumor

Mesh:

Substances:

Year:  2019        PMID: 30671724     DOI: 10.1007/s12253-019-00601-8

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  37 in total

1.  Penetrance of mutations in the familial Wilms tumor gene FWT1.

Authors:  N Rahman; L Arbour; R Houlston; C Bonaïti-Pellié; F Abidi; J Tranchemontagne; D Ford; S Narod; K Pritchard-Jones; W D Foulkes; C Schwartz; M R Stratton
Journal:  J Natl Cancer Inst       Date:  2000-04-19       Impact factor: 13.506

2.  Identification of microRNAs associated with lymphangiogenesis in human gastric cancer.

Authors:  B Yang; C Jing; J Wang; X Guo; Y Chen; R Xu; L Peng; J Liu; L Li
Journal:  Clin Transl Oncol       Date:  2013-07-24       Impact factor: 3.405

3.  The nuclear orphan receptor COUP-TFII is required for limb and skeletal muscle development.

Authors:  Christopher T Lee; Luoping Li; Norio Takamoto; James F Martin; Francesco J Demayo; Ming-Jer Tsai; Sophia Y Tsai
Journal:  Mol Cell Biol       Date:  2004-12       Impact factor: 4.272

Review 4.  Pathology, genetics and cytogenetics of Wilms' tumour.

Authors:  Reena Md Zin; Ashleigh Murch; Adrian Charles
Journal:  Pathology       Date:  2011-06       Impact factor: 5.306

5.  Overexpression of SIX1 is an independent prognostic marker in stage I-III colorectal cancer.

Authors:  Christoph Kahlert; Tristan Lerbs; Mathieu Pecqueux; Esther Herpel; Michael Hoffmeister; Lina Jansen; Hermann Brenner; Jenny Chang-Claude; Hendrik Bläker; Matthias Kloor; Wilfried Roth; Christian Pilarsky; Nuh N Rahbari; Sebastian Schölch; Ulrich Bork; Christoph Reissfelder; Jürgen Weitz; Daniela Aust; Moritz Koch
Journal:  Int J Cancer       Date:  2015-05-21       Impact factor: 7.396

Review 6.  The Wilms' tumor suppressor WT1: approaches to gene function.

Authors:  A Menke; L McInnes; N D Hastie; A Schedl
Journal:  Kidney Int       Date:  1998-06       Impact factor: 10.612

7.  Identification of hsa-miR-335 as a prognostic signature in gastric cancer.

Authors:  Zhi Yan; Yimin Xiong; Weitian Xu; Juan Gao; Yi Cheng; Zhigang Wang; Fang Chen; Guorong Zheng
Journal:  PLoS One       Date:  2012-07-03       Impact factor: 3.240

8.  International incidence of childhood cancer, 2001-10: a population-based registry study.

Authors:  Eva Steliarova-Foucher; Murielle Colombet; Lynn A G Ries; Florencia Moreno; Anastasia Dolya; Freddie Bray; Peter Hesseling; Hee Young Shin; Charles A Stiller
Journal:  Lancet Oncol       Date:  2017-04-11       Impact factor: 41.316

9.  Delineation of a 1Mb breakpoint region at 1p13 in Wilms tumors by fine-tiling oligonucleotide array CGH.

Authors:  Rachael Natrajan; Richard D Williams; Anita Grigoriadis; Alan Mackay; Kerry Fenwick; Alan Ashworth; Jeffrey S Dome; Paul E Grundy; Kathy Pritchard-Jones; Chris Jones
Journal:  Genes Chromosomes Cancer       Date:  2007-06       Impact factor: 5.006

10.  Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications.

Authors:  George D Cresswell; John R Apps; Tasnim Chagtai; Borbala Mifsud; Christopher C Bentley; Mariana Maschietto; Sergey D Popov; Mark E Weeks; Øystein E Olsen; Neil J Sebire; Kathy Pritchard-Jones; Nicholas M Luscombe; Richard D Williams; William Mifsud
Journal:  EBioMedicine       Date:  2016-05-27       Impact factor: 8.143

View more
  1 in total

1.  Correlations between histological characterizations and methylation statuses of tumour suppressor genes in Wilms' tumours.

Authors:  Yen-Chein Lai; Meng-Yao Lu; Wen-Chung Wang; Tai-Cheng Hou; Chen-Yun Kuo
Journal:  Int J Exp Pathol       Date:  2022-04-18       Impact factor: 2.793

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.